Sector News

New Perrigo Co. CEO is pharmaceutical industry veteran Uwe Rohrhoff

January 9, 2018
Life sciences

Perrigo Co.’s new chief executive officer is Uwe Rohrhoff, a 25-year veteran of the pharmaceutical industry.

The board of directors of the generic pharmaceuticals maker announced the appointment Monday morning, Jan. 8.

Rohrhoff has been named president and CEO, effective Jan. 15, 2018, following the retirement of John T. Hendrickson.

Hendrickson, who has worked for Perrigo since 1989, served as the company’s top executive since April of 2016. His plans to retire were announced in June.

Speaking of Rohrhoff, Perrigo Chairman Laurie Brlas stated in a press release, “He is an experienced, well-respected and successful CEO. Uwe brings a strong track record of operational excellence, strategic growth and healthcare supply chain management.”

Rohrhoff has worked since 1991 for Gerresheimer AG, a global manufacturer of pharmaceutical packaging products and medical devices for storage, dosage and safe administration of drugs. He has been CEO of that corporation since 2010.

Gerresheimer AG is a publicly-traded company that serves the pharmaceutical and healthcare industries. It is based on Dusseldorf, Germany.

“Uwe’s transformative strategic vision and focus on operational excellence enhanced the company’s leading market positions and created significant value for shareholders of approximately 225 percent in total shareholder return as CEO,” Brias said. “We are confident that his leadership style and industry, financial and operational expertise are the right fit for Perrigo.”

Commenting on the opportunities ahead for Perrigo in the press release, Rohrhoff said, “I am excited for the opportunity at Perrigo. I look forward to working with Perrigo’s experienced management team, who have been instrumental in positioning the company’s consumer OTC (over-the-counter) and prescription pharmaceutical businesses to capitalize on current trends in the market.”

He said he has long admired Perrigo and its mission “to deliver high-quality, affordable healthcare products that improve the lives of patients and families.”

Regarding Hendrickson, Brlas said, “We are grateful to John for his passionate leadership and contributions to the company over the past 28 years. John has been a trusted leader, a great colleague, and a friend to many, and we value his continued guidance as Uwe transitions into his new role.”

Perrigo Co. was founded in Allegan and the county continues to be the company’s largest center of operations. It has about 4,000 employees in West Michigan. The corporation’s global headquarters is now Dublin, Ireland.

By Al Jones

Source: MLive

comments closed

Related News

September 25, 2022

Rise of the machines: Novo Nordisk pledges $200M to create first quantum computer for life sciences

Life sciences

Big Pharma has long seen the potential for AI and machine learning to accelerate drug development. But Novo Nordisk is going a step further by channeling $200 million toward the creation of a computer that will outrun anything in existence.

September 25, 2022

Mount Sinai AI uncovers new brain analysis method to predict dementia, Alzheimer’s disease

Life sciences

Current methods for diagnosing Alzheimer’s disease rely on a complex combination of self- and caregiver-reported symptoms, a physical examination and either a PET scan or a spinal tap to look for evidence of amyloid plaque build-ups in the brain. But a new artificial intelligence-based method may make the diagnostic process a much more objective one.

September 25, 2022

New AstraZeneca-backed report finds big money behind diverse owners and entrepreneurs in Europe

Life sciences

There is lots of talk about diversity and inclusion in business, including in pharma and medtech. A new report by the Open Political Economy Network (OPEN), a think tank focusing on migration and diversity, released its “Minority Businesses Matter: Europe” report highlighting the successes and challenges of ethnic minority-owned businesses in Europe.